Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
- Author
- STEPAN, J. J1 ; BURR, D. B2 3 ; LI, J4 ; MA, Y. L5 ; PETTO, H5 ; SIPOS, A5 ; DOBNIG, H6 ; FAHRLEITNER-PAMMER, A6 ; MICHALSKA, D7 ; PAVO, I5
[1] Institute of Rheumatology, Faculty of Medicine, Charles University, Na Slupi 4, CZ12850 Prague, Czech Republic
[2] Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States
[3] Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN, United States
[4] Department of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, United States
[5] Lilly Research Laboratories, Indianapolis, IN, United States
[6] Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria
[7] Department of Internal Medicine 3, Faculty of Medicine, Charles University, Prague, Czech Republic - Source
Osteoporosis international. 2010, Vol 21, Num 12, pp 2027-2036, 10 p ; ref : 43 ref
- ISSN
- 0937-941X
- Scientific domain
- Rheumatology
- Publisher
- Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Alendronate Biochemical markers Bone turnover Histomorphometry Osteoporosis Teriparatide
- Keyword (fr)
- Acide alendronique Antiostéoclastique Antiostéoporotique Femme Ostéoporose Remodelage osseux Rhumatologie Tériparatide Homme Pathologie du système ostéoarticulaire
- Keyword (en)
- Alendronic acid Antiosteoclastic agent Antiosteoporotic Woman Osteoporosis Bone remodeling Rheumatology Teriparatide Human Diseases of the osteoarticular system
- Keyword (es)
- Acido alendrónico Antiosteoclástica Antiosteoporótico Mujer Osteoporosis Remodelado óseo Reumatología Teriparatida Hombre Sistema osteoarticular patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A23 Vertebrates: osteoarticular system, musculoskeletal system / 002A23A Skeleton and joints
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15A Osteoporosis. Osteomalacia. Paget disease
- Discipline
- Osteoarticular pathology Pharmacological treatments Vertebrates : osteoarticular system, musculoskeletal system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23432103
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00198-009-1168-7 
https://dx.doi.org/10.1007/s00198-009-1168-7
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00198-009-1168-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:91:\"Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Osteoporosis international\";s:9:\"\u0000*\u0000stitle\";s:15:\"Osteoporos. int\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2027\";s:8:\"\u0000*\u0000epage\";s:4:\"2036\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0937-941X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"STEPAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"J. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:10:\"BURR, D. B\";i:1;s:5:\"LI, J\";i:2;s:8:\"MA, Y. L\";i:3;s:8:\"PETTO, H\";i:4;s:8:\"SIPOS, A\";i:5;s:9:\"DOBNIG, H\";i:6;s:21:\"FAHRLEITNER-PAMMER, A\";i:7;s:12:\"MICHALSKA, D\";i:8;s:7:\"PAVO, I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:91:\"Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
